Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Sales growth has restarted. Margins contracted slightly. Revenues increased by 36% from the same quarter a year prior. They overall missed their quarter but growth prospects still look pretty good. Unlock Premium - Try 5i Free
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Competition in the space has increased. The valuation has reached above 6x sales. Valuation is more reasonable at 3x sales. The company also has small cap risk but sales growth has been strong. A 5+ years time horizon. Unlock Premium - Try 5i Free
VitalHub Corp. is a Canadian stock, trading under the symbol VHI-X on the TSX Venture Exchange (VHI-CV). It is usually referred to as TSXV:VHI or VHI-X
In the last year, 3 stock analysts published opinions about VHI-X. 3 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for VitalHub Corp..
VitalHub Corp. was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for VitalHub Corp..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
3 stock analysts on Stockchase covered VitalHub Corp. In the last year. It is a trending stock that is worth watching.
On 2021-09-22, VitalHub Corp. (VHI-X) stock closed at a price of $2.98.
Healthcare tech company.
Has owned on and off over the past few years.
Very strong management team.
Multiple is high given current share price.
Defensive software name.